Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation-Reference-Cited by-同舟云学术

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

Published:2019-11-18 Issue:1 Volume:1 Page:86-98
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Wu Lan,Seung Edward,Xu Ling,Rao Ercole,Lord Dana M.,Wei Ronnie R.^ORCID,Cortez-Retamozo Virna,Ospina Beatriz,Posternak Valeriya,Ulinski Gregory,Piepenhagen Peter,Francesconi Elisa,El-Murr Nizar^ORCID,Beil Christian,Kirby Patrick,Li Aiqun,Fretland Jennifer,Vicente Rita,Deng Gejing,Dabdoubi Tarik,Cameron Beatrice,Bertrand Thomas^ORCID,Ferrari Paul,Pouzieux Stéphanie,Lemoine Cendrine,Prades Catherine,Park Anna,Qiu Huawei,Song Zhili,Zhang Bailin,Sun Fangxian,Chiron Marielle,Rao Srinivas,Radošević Katarina^ORCID,Yang Zhi-yong^ORCID,Nabel Gary J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s43018-019-0004-z.pdf

Reference71 articles.

1. Bhoj, V. G. et al. Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy. Blood 128, 360–370 (2016).

2. Hui, R. et al. Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial. Ann. Oncol. 28, 874–881 (2017).

3. Leach, D. R., Krummel, M. F. & Allison, J. P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734–1736 (1996).

4. Zuniga, E. I., Macal, M., Lewis, G. M. & Harker, J. A. Innate and adaptive immune regulation during chronic viral infections. Annu. Rev. Virol. 2, 573–597 (2015).

5. Vesely, M. D., Kershaw, M. H., Schreiber, R. D. & Smyth, M. J. Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29, 235–271 (2011).

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific antibodies in the treatment of multiple myeloma;Blood Cancer Journal;2024-09-12

2. Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies;The Lancet Haematology;2024-09

3. Micro-flow cell washing technique combined with single-cell Raman spectroscopy for rapid and automatic antimicrobial susceptibility test of pathogen in urine;Talanta;2024-09

4. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma;Blood Neoplasia;2024-09

5. NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity;Cancer Immunology, Immunotherapy;2024-08-08